Literature DB >> 27766596

Effects of acupuncture on quality of life and pain in patients with osteoporosis-a pilot randomized controlled trial.

Joerg Schiller1, Christoph Korallus2, Matthias Bethge2,3, Matthias Karst4, Marie-Lena Schmalhofer2, Christoph Gutenbrunner2, Matthias Georg Fink5.   

Abstract

In this sham-controlled study, 53 patients received 10 sessions of acupuncture treatment over 5 weeks to investigate the effects of acupuncture on the pain and quality of life of patients with osteoporosis. The results showed significant favorable effects of verum acupuncture on quality of life. Both interventions showed sustained and clinically relevant effects on pain.
PURPOSE: Standard analgesic treatment is associated with adverse events in patients with osteoporosis, especially elderly and/or comorbid patients. As acupuncture has gained widespread acceptance as a complementary treatment modality with few side effects, the aim of this study was to evaluate the effects of acupuncture on the pain and quality of life of patients with osteoporosis.
METHODS: In total, 53 patients with vertebral compression fractures, osteoporosis-associated spinal deformities, and resultant pain were randomly allocated to the verum acupuncture with deep needling of specific points following the principles of traditional Chinese medicine (n = 29) or control acupuncture group with superficial needling of non-acupuncture points (n = 24). All patients received 10 sessions of standardized verum or control acupuncture treatment over 5 weeks. Pain (VAS score 1-100) and quality of life (QUALEFFO-41) were measured at the start of treatment (T0), before each acupuncture session (T1), and at 1 (T2) and 3 months (T3) post-treatment.
RESULTS: Both acupuncture treatments significantly reduced activity-related pain and pain at rest over time. The verum acupuncture group experienced a significantly greater reduction in mean pain intensity at rest than the control group. In the control group, quality of life improved only temporarily post-treatment (T2) and slightly declined at the end of the follow-up period (T3). In contrast, patients in the verum acupuncture group experienced continuous and significant improvements in quality of life up to 3 months after treatment (T3).
CONCLUSIONS: Both types of acupuncture were equally effective in producing sustained, clinically relevant pain relief in patients with osteoporosis. Verum acupuncture had stronger and longer-lasting effects on quality of life and pain at rest. The possible reasons for these findings include the specificity of acupuncture point selection and the performance of needle stimulation.

Entities:  

Keywords:  Acupuncture; Osteoporosis; Pain; QUALEFFO-41; Quality of life

Mesh:

Year:  2016        PMID: 27766596     DOI: 10.1007/s11657-016-0288-x

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  4 in total

1.  Effect of acupuncture combined with early rehabilitation training on postoperative dysfunction and quality of life of patients undergoing total knee arthroplasty.

Authors:  Runzhi Li; Zhendi Xu; Yuankuan Li; Jihong Luo
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Acupuncture as Part of Multimodal Analgesia for Chronic Pain.

Authors:  Christopher L Robinson; Amnon Berger; Emily Sottosanti; Michael Li; Alicia Kaneb; Joseph Keefe; Edward Kim; Alan Kaye; Omar Viswanath; Ivan Urits
Journal:  Orthop Rev (Pavia)       Date:  2022-09-23

3.  Evaluating the Characteristics, Reporting and Methodological Quality of Systematic Reviews of Acupuncture for Low Back Pain by Using the Veritas Plot.

Authors:  Fan Huang; Mingwang Qiu; Siyi Zhao; Lin Dai; Yanpeng Xu; Yunying Yang; Liming Lu; Rusong Guo; Qiang Tian; Zhiyong Fan; Shan Wu
Journal:  J Pain Res       Date:  2020-10-19       Impact factor: 3.133

Review 4.  Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach.

Authors:  Antonino Catalano; Gabriella Martino; Nunziata Morabito; Claudia Scarcella; Agostino Gaudio; Giorgio Basile; Antonino Lasco
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.